ENSC
Price
$0.53
Change
-$0.05 (-8.62%)
Updated
Nov 5, 11:00 AM (EDT)
HOWL
Price
$2.28
Change
+$0.02 (+0.88%)
Updated
Nov 5, 11:18 AM (EDT)
2 days until earnings call
Ad is loading...

ENSC vs HOWL

Header iconENSC vs HOWL Comparison
Open Charts ENSC vs HOWLBanner chart's image
Ensysce Biosciences
Price$0.53
Change-$0.05 (-8.62%)
Volume$2.97K
CapitalizationN/A
Werewolf Therapeutics
Price$2.28
Change+$0.02 (+0.88%)
Volume$300
CapitalizationN/A
View a ticker or compare two or three
ENSC vs HOWL Comparison Chart
Loading...
ENSC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
HOWL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ENSC vs. HOWL commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENSC is a Hold and HOWL is a Buy.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (ENSC: $0.57 vs. HOWL: $2.27)
Brand notoriety: ENSC and HOWL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENSC: 45% vs. HOWL: 115%
Market capitalization -- ENSC: $8.47M vs. HOWL: $98.99M
ENSC [@Biotechnology] is valued at $8.47M. HOWL’s [@Biotechnology] market capitalization is $98.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $498.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENSC’s FA Score shows that 0 FA rating(s) are green whileHOWL’s FA Score has 1 green FA rating(s).

  • ENSC’s FA Score: 0 green, 5 red.
  • HOWL’s FA Score: 1 green, 4 red.
According to our system of comparison, HOWL is a better buy in the long-term than ENSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENSC’s TA Score shows that 6 TA indicator(s) are bullish while HOWL’s TA Score has 3 bullish TA indicator(s).

  • ENSC’s TA Score: 6 bullish, 4 bearish.
  • HOWL’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ENSC is a better buy in the short-term than HOWL.

Price Growth

ENSC (@Biotechnology) experienced а +70.70% price change this week, while HOWL (@Biotechnology) price change was -23.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +14.28%, and the average quarterly price growth was +9.89%.

Reported Earning Dates

ENSC is expected to report earnings on May 15, 2023.

HOWL is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HOWL($99M) has a higher market cap than ENSC($8.47M). HOWL YTD gains are higher at: -41.321 vs. ENSC (-46.406). ENSC has higher annual earnings (EBITDA): -9.65M vs. HOWL (-47.75M). HOWL has more cash in the bank: 135M vs. ENSC (1.04M). ENSC has less debt than HOWL: ENSC (454K) vs HOWL (36.7M). HOWL has higher revenues than ENSC: HOWL (9.28M) vs ENSC (0).
ENSCHOWLENSC / HOWL
Capitalization8.47M99M9%
EBITDA-9.65M-47.75M20%
Gain YTD-46.406-41.321112%
P/E RatioN/AN/A-
Revenue09.28M-
Total Cash1.04M135M1%
Total Debt454K36.7M1%
FUNDAMENTALS RATINGS
ENSC: Fundamental Ratings
ENSC
OUTLOOK RATING
1..100
30
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENSCHOWL
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 21 days ago
81%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ENSC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
HOWL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NDBKY17.390.33
+1.93%
Nedbank Group, Ltd.
NEXCF0.04N/A
+0.24%
NexTech3D.AI Corp.
BASFY12.18-0.09
-0.69%
BASF SE
FSNUY9.10-0.15
-1.62%
Fresenius SE & Co. KGaA
MDNAF1.70-0.11
-6.08%
Medicenna Therapeutics Corp.

ENSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENSC has been loosely correlated with MLLCF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ENSC jumps, then MLLCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENSC
1D Price
Change %
ENSC100%
-12.60%
MLLCF - ENSC
37%
Loosely correlated
N/A
ALLK - ENSC
36%
Loosely correlated
-1.57%
HNSBF - ENSC
33%
Loosely correlated
N/A
GNPX - ENSC
33%
Poorly correlated
-6.05%
HOWL - ENSC
31%
Poorly correlated
-8.67%
More

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with GBIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
-8.67%
GBIO - HOWL
41%
Loosely correlated
-1.81%
ABOS - HOWL
37%
Loosely correlated
+3.69%
GNPX - HOWL
37%
Loosely correlated
-6.05%
ALLO - HOWL
37%
Loosely correlated
+10.29%
KYMR - HOWL
35%
Loosely correlated
+1.29%
More